Ouro Fino Saúde Animal Participações S.A (SA:OFSA3) — Market Cap & Net Worth
Market Cap & Net Worth: Ouro Fino Saúde Animal Participações S.A (OFSA3)
Ouro Fino Saúde Animal Participações S.A (SA:OFSA3) has a market capitalization of $324.95 Million (R$1.66 Billion) as of June 17, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #14570 globally and #140 in its home market, demonstrating a 3.01% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ouro Fino Saúde Animal Participações S.A's stock price R$30.80 by its total outstanding shares 53767606 (53.77 Million). Review Ouro Fino Saúde Animal Participações S.A debt and liabilities to assess the company's total debt and financial obligations.
Ouro Fino Saúde Animal Participações S.A Market Cap History: 2015 to 2026
Ouro Fino Saúde Animal Participações S.A's market capitalization history from 2015 to 2026. Data shows growth from $325.27 Million to $324.95 Million (0.04% CAGR).
Ouro Fino Saúde Animal Participações S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ouro Fino Saúde Animal Participações S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.20x
Ouro Fino Saúde Animal Participações S.A's market cap is 0.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.09x
Ouro Fino Saúde Animal Participações S.A's market cap is 1.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $261.59 Million | $456.59 Million | -$5.21 Million | 0.57x | N/A |
| 2017 | $225.23 Million | $505.28 Million | $38.11 Million | 0.45x | 5.91x |
| 2018 | $319.43 Million | $589.22 Million | $68.85 Million | 0.54x | 4.64x |
| 2019 | $410.10 Million | $619.59 Million | $46.28 Million | 0.66x | 8.86x |
| 2020 | $367.58 Million | $730.11 Million | $89.72 Million | 0.50x | 4.10x |
| 2021 | $251.05 Million | $904.99 Million | $113.96 Million | 0.28x | 2.20x |
| 2022 | $246.82 Million | $1.04 Billion | $130.66 Million | 0.24x | 1.89x |
| 2023 | $265.89 Million | $943.28 Million | -$49.98 Million | 0.28x | N/A |
| 2024 | $204.15 Million | $1.02 Billion | $814.39 Million | 0.20x | 0.25x |
| 2025 | $242.65 Million | $1.22 Billion | $222.31 Million | 0.20x | 1.09x |
Competitor Companies of OFSA3 by Market Capitalization
Companies near Ouro Fino Saúde Animal Participações S.A in the global market cap rankings as of June 17, 2026.
Key companies related to Ouro Fino Saúde Animal Participações S.A by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #512 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #613 globally with a market cap of $44.69 Billion USD ( CN¥305.43 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #629 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #512 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.41 |
| #613 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.69 Billion | CN¥47.88 |
| #629 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
Ouro Fino Saúde Animal Participações S.A Historical Marketcap From 2015 to 2026
Between 2015 and today, Ouro Fino Saúde Animal Participações S.A's market cap moved from $325.27 Million to $ 324.95 Million, with a yearly change of 0.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$324.95 Million | +33.91% |
| 2025 | R$242.65 Million | +18.86% |
| 2024 | R$204.15 Million | -23.22% |
| 2023 | R$265.89 Million | +7.73% |
| 2022 | R$246.82 Million | -1.69% |
| 2021 | R$251.05 Million | -31.70% |
| 2020 | R$367.58 Million | -10.37% |
| 2019 | R$410.10 Million | +28.39% |
| 2018 | R$319.43 Million | +41.82% |
| 2017 | R$225.23 Million | -13.90% |
| 2016 | R$261.59 Million | -19.58% |
| 2015 | R$325.27 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Ouro Fino Saúde Animal Participações S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $324.95 Million USD |
| MoneyControl | $324.95 Million USD |
| MarketWatch | $324.95 Million USD |
| marketcap.company | $324.95 Million USD |
| Reuters | $324.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ouro Fino Saúde Animal Participações S.A
Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including an… Read more